← Back to Clinical Trials
Recruiting NCT07597356

NCT07597356 AI-Based Video Analysis for Motor Development Assessment in Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07597356
Status Recruiting
Phase
Sponsor Medipol University
Condition Motor Development Assessment
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2026-01-01
Primary Completion 2026-08-01

Eligibility & Interventions

Sex All sexes
Min Age 5 Years
Max Age 10 Years
Study Type OBSERVATIONAL
Interventions
Observational Assessment Only

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 60 participants in total. It began in 2026-01-01 with a primary completion date of 2026-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is a non-interventional, prospective observational study aimed at developing and validating an artificial intelligence-based system for assessing motor development in children using video analysis. Children aged 5 to 10 years will perform standardized motor tasks, which will be recorded under controlled conditions. The recorded videos will be analyzed using computer vision and deep learning techniques to extract movement patterns. The results of the AI-based analysis will be compared with standardized motor assessment scores obtained from the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition - Short Form (BOT-2 SF). Participants will be classified into typical and atypical motor development groups based on BOT-2 scores. The primary objective is to evaluate the classification performance of the AI model. Secondary analyses will examine the relationship between AI predictions and continuous motor performance scores. The study is designed to explore whether motor development can be assessed objectively without direct clinical testing, using only short video recordings. The findings may contribute to the development of scalable and accessible digital screening tools for early identification of motor development differences in children.

Eligibility Criteria

Inclusion Criteria: * Children aged between 5 and 10 years * No diagnosed neurological, developmental, or orthopedic disorders * Ability to follow verbal instructions * Informed consent obtained from parents or legal guardians * No prior participation in sensory integration therapy or special education programs Exclusion Criteria: * Diagnosed neurological, developmental, or orthopedic conditions (e.g., autism spectrum disorder, cerebral palsy, epilepsy) * Visual or hearing impairments affecting task performance * Severe attention or behavioral problems preventing test completion * Physical limitations preventing participation in motor tasks

Contact & Investigator

Central Contact

Abdullah Furkan Cangi, Msc

✉ abdullah.cangi@medipol.edu.tr

📞 +90 553 622 7898

Frequently Asked Questions

Who can join the NCT07597356 clinical trial?

This trial is open to participants of all sexes, aged 5 Years or older, up to 10 Years, studying Motor Development Assessment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07597356 currently recruiting?

Yes, NCT07597356 is actively recruiting participants. Contact the research team at abdullah.cangi@medipol.edu.tr for enrollment information.

Where is the NCT07597356 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07597356 clinical trial?

NCT07597356 is sponsored by Medipol University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology